Safety Evaluation of 3K3A-APC in Ischemic Stroke "RHAPSODY"

Active, not recruiting

Phase 2 Results N/A



  • Lyden P, Levy H, Weymer S, Pryor K, Kramer W, Griffin JH, Davis TP, Zlokovic B. Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr Pharm Des. 2013;19(42):7479-85. Pubmed ID:24372304

Related Links

Sources for Trial Information